000 | 01599 a2200457 4500 | ||
---|---|---|---|
005 | 20250513154414.0 | ||
264 | 0 | _c19981207 | |
008 | 199812s 0 0 eng d | ||
022 | _a0022-3565 | ||
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aGriswold, D E | |
245 | 0 | 0 |
_aSB 207499 (Ariflo), a second generation phosphodiesterase 4 inhibitor, reduces tumor necrosis factor alpha and interleukin-4 production in vivo. _h[electronic resource] |
260 |
_bThe Journal of pharmacology and experimental therapeutics _cNov 1998 |
||
300 |
_a705-11 p. _bdigital |
||
500 | _aPublication Type: Journal Article | ||
650 | 0 | 4 |
_a3',5'-Cyclic-AMP Phosphodiesterases _xantagonists & inhibitors |
650 | 0 | 4 | _aAdoptive Transfer |
650 | 0 | 4 | _aAnimals |
650 | 0 | 4 | _aCyclic Nucleotide Phosphodiesterases, Type 4 |
650 | 0 | 4 |
_aCyclohexanecarboxylic Acids _xpharmacology |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 |
_aInterleukin-4 _xantagonists & inhibitors |
650 | 0 | 4 | _aMale |
650 | 0 | 4 | _aMice |
650 | 0 | 4 | _aMice, Inbred Strains |
650 | 0 | 4 | _aMonocytes |
650 | 0 | 4 | _aNitriles |
650 | 0 | 4 |
_aPhosphodiesterase Inhibitors _xpharmacology |
650 | 0 | 4 |
_aPyrrolidinones _xpharmacology |
650 | 0 | 4 | _aRolipram |
650 | 0 | 4 |
_aTumor Necrosis Factor-alpha _xantagonists & inhibitors |
700 | 1 | _aWebb, E F | |
700 | 1 | _aBadger, A M | |
700 | 1 | _aGorycki, P D | |
700 | 1 | _aLevandoski, P A | |
700 | 1 | _aBarnette, M A | |
700 | 1 | _aGrous, M | |
700 | 1 | _aChristensen, S | |
700 | 1 | _aTorphy, T J | |
773 | 0 |
_tThe Journal of pharmacology and experimental therapeutics _gvol. 287 _gno. 2 _gp. 705-11 |
|
999 |
_c9773048 _d9773048 |